Answers are grounded in this paper and cite their sources.
There is dire need to properly implement price control policies to better regulate fragile antibiotic supply system so that the availability of both OB and LPG of key access antibiotics should be increased. The prices could be reduced by improving purchasing efficiency, excluding taxes and regulating mark-ups. This could increase the affordability of patients to complete their antibiotic therapy with subsequent reduction in antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
Saleem et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: